Showing publications 1 - 5 of 5 (Page 1 of 1)
Two-stage approach for risk estimation of fetal trisomy 21 and other aneuploidies using computational intelligence systems.
Neocleous AC, Syngelaki A, Nicolaides KH, Schizas CN.
Ultrasound Obstet Gynecol 2018;51:503-508. pdf
Intelligent Non-invasive Diagnosis of Aneuploidy: Raw Values and Highly Imbalanced Dataset.
Neocleous A, Nicolaides K, Schizas C.
IEEE J Biomed Health Inform DOI: 10.1109/JBHI.2016.2608859 pdf
First-trimester contingent screening for trisomies 21, 18 and 13 by fetal nuchal translucency and ductus venosus flow and maternal blood cell-free DNA testing.
Kagan KO, Wright D, Nicolaides KH.
Ultrasound Obstet Gynecol 2015;45:42-7 pdf
Screening for fetal aneuploidies at 11 to 13 weeks.
Prenat Diagn 2011;31:7-15 pdf
A model for a new pyramid of prenatal care based on the 11 to 13 weeks' assessment.
Prenat Diagn 2011;31:3-6 pdf